• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Hyderus

Hyderus Cyf and Hyderus Teoranta

Pandemicast
  • Home
  • Tell the Truth
    • Videos
  • About us
    • Access to innovative medicines
    • New Work in India
    • Mark Chataway
    • We pay our taxes
    • Our approach to managing risk perception and crises
    • African journalists we respect
  • Customers
  • Expertise
    • Development and Politics
      • Assessing science policy in 48 African countries
      • The future of European development funding
      • The link between family planning and climate change
      • What are the influence networks in health?
    • Knowledge Transfer and Capacity Building
      • For senior executives
      • For the online world
      • To manage international politics
    • Public Health
      • Drivers and barriers for new vaccines
    • Strategic Planning
      • Avoiding a crisis in the Middle East
      • Developing BRICS countries as donors
      • For an international organisation in India
      • Increasing immunization coverage in central India
      • Setting up systems for issues management
    • Treatment Decisions
      • How to get healthcare systems to care for older women
      • Immunisation for adults
      • Stakeholders and corporate social responsibility
  • Contact
  • Blog
    • What we’re thinking
    • Our World
    • Staff blog
  • Flexible Pricing Plan

health policy

US malaria donations saving two million children?

June 6, 2018 by Nicholas Parry Leave a Comment

By Chief Petty Officer Robert Gallagher (https://www.dvidshub.net/image/227675) [Public domain], via Wikimedia Commons

Have US donations in the campaign to fight malaria been responsible for saving the lives of up to two million children in Africa? Foreign aid often faces the accusation of not being cost efficient, or poorly directed. In many cases there are a lack of follow up studies analysing the impact of the donations. A study published in PLOS Medicine is … [Read more...] about US malaria donations saving two million children?

Filed Under: Featured, Staff blog Tagged With: access to healthcare, access to medicines, Africa, Development, Donald Trump, health policy, malaria, public health

Mexico City Policy: Putting the US at odds with the EU?

September 23, 2017 by Nicholas Parry Leave a Comment

By Voice of America (http://www.voanews.com/a/3430100.html) [Public domain], via Wikimedia Commons

The London Family Planning summit has reportedly documented $5 billion in pledges to aid family planning services in developing nations, however, will the policies of the Trump administration hinder these efforts? On Tuesday, July 11, World Population Day was observed, with a timely theme: “Family Planning: Empowering People, Developing … [Read more...] about Mexico City Policy: Putting the US at odds with the EU?

Filed Under: Featured, Staff blog Tagged With: abortion, access to medicines, Africa, Development, Donald Trump, family planning, foreign policy, health policy, healthcare, public health

Hype for UN’s report on access to medicines is confused and contradictory

September 19, 2016 by Mark Chataway 1 Comment

The first sentence of the official press release for the new UN report on access to medicines captures all the problems with the report, probably inadvertently. Here is the monster sentence   Whether it’s the rising price of the EpiPen, or new outbreaks of diseases, like Ebola, Zika and yellow fever, the rising costs of health technologies … [Read more...] about Hype for UN’s report on access to medicines is confused and contradictory

Filed Under: Featured Tagged With: access to medicines, health policy, pharmaceutical industry, public health

Policy dialogue in the Twitter age

February 11, 2016 by Mark Chataway Leave a Comment

The UN Secretary General has a High Level Panel on Access to Medicines. Helen Clark, the Administrator (Chief Executive) of UNDP and a former prime Minister of New Zealand, recorded a video for the panel members. She discussed UNDP's accomplishments in getting the price of medicines cut for African countries, including Equatorial Guinea. Equatorial … [Read more...] about Policy dialogue in the Twitter age

Filed Under: Featured Tagged With: health policy, Twitter; policy and social media

Access to advanced medicines and affordability: a look forward to 2016

January 2, 2016 by Mark Chataway 2 Comments

We think that there will be unparalleled attention in 2016 on the issues of access to advanced medicines and on how to pay for them. Past controversies have largely focussed on access in low and middle income countries; this time Europe and North America will command at least as much attention. Ironically, the world’s richest and the poorest will … [Read more...] about Access to advanced medicines and affordability: a look forward to 2016

Filed Under: Featured Tagged With: access to medicines, cancer, health policy, patents, pharmaceutical industry

Five myths about access to medicines in emerging markets

July 22, 2015 by Mark Chataway 1 Comment

Pharma companies can have an “emerging markets strategy”   Emerging markets are nothing like one another: an Argentinian denied an expensive new drug will usually just go and get a court to order his insurer or the state to pay for it; an Indonesian may never even find out what’s wrong with him.  Argentina spends about $1050 per person on … [Read more...] about Five myths about access to medicines in emerging markets

Filed Under: Our craft Tagged With: access to medicines, Global Health Progress, health policy, pharmaceutical industry

The basics about spending on health around the world

July 21, 2015 by Mark Chataway 1 Comment

Most industrialised countries use about nine percent of GDP for government health spending and about 11 percent of GDP for overall health spending (public and private combined). This chart from the World Bank (based on WHO data) shows the percentage of GDP spent by governments on health and this one the overall health spending.   The … [Read more...] about The basics about spending on health around the world

Filed Under: Our craft Tagged With: health policy, health spending, public health, WHO

The failure of global health advocacy spelled out in numbers

July 11, 2015 by Mark Chataway Leave a Comment

No fashionable university is without its own department doing studies and advocacy on global health these days and NGOs and consultancies proliferate. Richard Horton and his team at The Lancet seem to produce ever more elaborate reports and commissions demanding an extra $30 billion here or $50 billion there. None of them tell you that funding for … [Read more...] about The failure of global health advocacy spelled out in numbers

Filed Under: Featured Tagged With: advocacy, Global Health Progress, health policy, public health

International declarations and treaties don’t change things — Tweets do

July 10, 2015 by Mark Chataway 1 Comment

There was a time when international declarations changed the world. Maybe some still do but increasingly leaders communicate in 140 characters, not 20-page communiqués. Even international agreements and treaties may not be worth the paper they're written on, much less the thousands of days of staff time that go into them, according to an elegant … [Read more...] about International declarations and treaties don’t change things — Tweets do

Filed Under: Featured Tagged With: Africa, Global Health Progress, health policy, international treaties

Does bad qualitative research guide US policy?

November 24, 2014 by Mark Chataway Leave a Comment

Last week, the US Centers for Disease Control posted an interesting article (in advance of publication in Emerging Infectious Diseases) on attitudes to antibiotic resistance amongst primary care providers. It is full of good ideas and it might even reflect what US providers think. As a basis for public policy, though, it is dangerously inadequate. … [Read more...] about Does bad qualitative research guide US policy?

Filed Under: Featured Tagged With: antibiotics, health policy, qualitative research

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

Categories

  • Featured (206)
  • Our craft (22)
  • Staff blog (56)
access to medicines Africa Chris Nial climate change communications consultancy coronavirus COVID-19 Development Donald Trump environment foreign policy Global Health Progress global warming green energy health healthcare health policy HIV Hyderus india Mark Chataway ODA PandemiCast patents pharmaceutical industry public health vaccination vaccines wales WHO

Hyderus on Twitter

Tweets by Hyderus

Hyderus on Facebook

Videos

The Three Commitments
Why Consultants end up not telling the truth
The worst kind of market research interviewing technique ever
Why bright people can’t explain themselves
More videos

Clients

 
 
 

Footer

Looking For?

  • Our World
  • Contact us
  • Privacy Policy
  • Terms of use

Recent Posts

  • Accessible healthcare could aid climate crisis in rainforest communities
  • Climate change impact has the potential to regress cancer progress through healthcare disruption, according to study
  • Vaccines and COVID-19: Frans van den Boom speaks to Hyderus and Baird’s CMC

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Copyright © 2021 Hyderus. All rights reserved. Sitemap

  • Home
  • Tell the Truth
    ▼
    • Videos
  • About us
    ▼
    • Access to innovative medicines
    • New Work in India
    • Mark Chataway
    • We pay our taxes
    • Our approach to managing risk perception and crises
    • African journalists we respect
  • Customers
  • Expertise
    ▼
    • Development and Politics
      ▼
      • Assessing science policy in 48 African countries
      • The future of European development funding
      • The link between family planning and climate change
      • What are the influence networks in health?
    • Knowledge Transfer and Capacity Building
      ▼
      • For senior executives
      • For the online world
      • To manage international politics
    • Public Health
      ▼
      • Drivers and barriers for new vaccines
    • Strategic Planning
      ▼
      • Avoiding a crisis in the Middle East
      • Developing BRICS countries as donors
      • For an international organisation in India
      • Increasing immunization coverage in central India
      • Setting up systems for issues management
    • Treatment Decisions
      ▼
      • How to get healthcare systems to care for older women
      • Immunisation for adults
      • Stakeholders and corporate social responsibility
  • Contact
  • Blog
    ▼
    • What we’re thinking
    • Our World
    • Staff blog
  • Flexible Pricing Plan

Cookies

This site uses cookies: Find out more.